Global Nintedanib Market Set for Significant Growth Amid Rising Demand in Respiratory and Fibrotic Diseases https://dataintelo.com/report/global-nintedanib-market The Nintedanib Market is rapidly expanding, driven by increasing prevalence of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and other fibrotic conditions. Enhanced awareness and improved diagnostic capabilities are further fueling the market’s upward trajectory, aligning closely with developments in the Study Abroad Agency Market globally. As of 2023, the market was valued at approximately USD 1.2 billion and is forecasted to grow at a CAGR of 11.8% from 2024 to 2030. This expansion reflects growing adoption of nintedanib as a preferred therapeutic option to slow disease progression and improve patient outcomes.